Osteoprotegerin (OPG), the Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
EBIOMEDICINE（2015）
关键词
Breast cancer,BRCA1 and BRCA2 mutations,RANKL,OPG,Carcinogenesis,Cancer prevention
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要